UK markets closed

Thermo Fisher Scientific Inc. (0R0H.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
573.73+1.58 (+0.28%)
At close: 07:11PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.80
52-week change 36.63%
S&P500 52-week change 323.10%
52-week high 3603.14
52-week low 3416.65
50-day moving average 3556.84
200-day moving average 3522.32

Share statistics

Avg vol (3-month) 313.25k
Avg vol (10-day) 312.78k
Shares outstanding 5402.58M
Implied shares outstanding 6N/A
Float 8381.11M
% held by insiders 10.18%
% held by institutions 192.14%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 31.44
Trailing annual dividend yield 30.25%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Mar 2024

Profitability

Profit margin 14.20%
Operating margin (ttm)16.68%

Management effectiveness

Return on assets (ttm)4.82%
Return on equity (ttm)13.62%

Income statement

Revenue (ttm)42.49B
Revenue per share (ttm)110.37
Quarterly revenue growth (yoy)-3.40%
Gross profit (ttm)N/A
EBITDA 10.78B
Net income avi to common (ttm)6.03B
Diluted EPS (ttm)19.19
Quarterly earnings growth (yoy)3.00%

Balance sheet

Total cash (mrq)7.25B
Total cash per share (mrq)18.98
Total debt (mrq)35.61B
Total debt/equity (mrq)78.05%
Current ratio (mrq)1.70
Book value per share (mrq)119.12

Cash flow statement

Operating cash flow (ttm)8.93B
Levered free cash flow (ttm)6.08B